Literature DB >> 22289147

Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.

S F O'Brien1, Q-L Yi, W Fan, V Scalia, M A Fearon, J-P Allain.   

Abstract

Estimates of the viral residual risk should be updated to reflect current incidence of infection in blood donors. Incidence rates were estimated for allogeneic whole-blood donations made to Canadian Blood Services from 2006 to 2009 based on transmissible disease conversions of repeat donations within a 3-year period. Residual risk was estimated as the incidence multiplied by the window period. The residual risk of HIV was 1 per 8 million donations, HCV 1 per 6·7 million donations and HBV 1 per 1·7 million donations. The residual risk remains low and has decreased for HCV since our previous estimates due to reduced incidence.
© 2012 The Author(s). Vox Sanguinis © 2012 International Society of Blood Transfusion.

Entities:  

Mesh:

Year:  2012        PMID: 22289147     DOI: 10.1111/j.1423-0410.2012.01584.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  27 in total

1.  Understanding Perioperative Transfusion Practices in Gastrointestinal Surgery-a Practice Survey of General Surgeons.

Authors:  Lavanya Yohanathan; Natalie G Coburn; Robin S McLeod; Daniel J Kagedan; Emily Pearsall; Francis S W Zih; Jeannie Callum; Yulia Lin; Stuart McCluskey; Julie Hallet
Journal:  J Gastrointest Surg       Date:  2016-03-29       Impact factor: 3.452

2.  The impact of blood transfusion on perioperative outcomes following gastric cancer resection: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database.

Authors:  Maryam Elmi; Alyson Mahar; Daniel Kagedan; Calvin H L Law; Paul J Karanicolas; Yulia Lin; Jeannie Callum; Natalie G Coburn; Julie Hallet
Journal:  Can J Surg       Date:  2016-09       Impact factor: 2.089

3.  A decision model and cost analysis of intra-operative cell salvage during hepatic resection.

Authors:  Madeline Lemke; Gareth Eeson; Yulia Lin; Jordan Tarshis; Julie Hallet; Natalie Coburn; Calvin Law; Paul J Karanicolas
Journal:  HPB (Oxford)       Date:  2016-03-09       Impact factor: 3.647

4.  Group testing case identification with biomarker information.

Authors:  Dewei Wang; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Comput Stat Data Anal       Date:  2018-02-01       Impact factor: 1.681

5.  A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors.

Authors:  Donald J Brambilla; Michael P Busch; Roger Y Dodd; Simone A Glynn; Steven H Kleinman
Journal:  Transfusion       Date:  2016-12-01       Impact factor: 3.157

6.  Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey.

Authors:  Claudio Velati; Luisa Romanò; Vanessa Piccinini; Giuseppe Marano; Liviana Catalano; Simonetta Pupella; Giuseppina Facco; Ilaria Pati; Maria Elena Tosti; Stefania Vaglio; Giuliano Grazzini; Alessandro Zanetti; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-06-26       Impact factor: 3.443

7.  Transfusion and risk of infection in Canada: Update 2012.

Authors:  Noni E Macdonald; Sheila F O'Brien; Gilles Delage
Journal:  Paediatr Child Health       Date:  2012-12       Impact factor: 2.253

8.  Estimating the prevalence of multiple diseases from two-stage hierarchical pooling.

Authors:  Md S Warasi; Joshua M Tebbs; Christopher S McMahan; Christopher R Bilder
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

9.  The impact of peri-operative blood transfusions on post-pancreatectomy short-term outcomes: an analysis from the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Julie Hallet; Alyson L Mahar; Melanie E Tsang; Yulia Lin; Jeannie Callum; Natalie G Coburn; Calvin H L Law; Paul J Karanicolas
Journal:  HPB (Oxford)       Date:  2015-08-24       Impact factor: 3.647

10.  Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors.

Authors:  Jingxing Wang; Jing Liu; Fuzhu Yao; Guoxin Wen; Julin Li; Yi Huang; Yunlai Lü; Xiuqiong Wen; David Wright; Qilu Yu; Nan Guo; Paul Ness; Hua Shan
Journal:  Transfusion       Date:  2012-11-01       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.